knowledge -WSS

knowledge

author：knowledge 2025-09-30 00:46:40 - browse：69

Adam's take main illustration — Molly Ferguson/STAT

Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics:

A take-under deal feels meh for biotech sector sentiment.Bristol is paying $58 per share in cash for Mirati, which closed Friday at $60. Granted, Mirati was trading in the $30 range in September, so from there, the roughly 50% premium isn’t terrible. But as Mizuho strategist Jared Holz pointed out, investors would liked to have seen Mirati go for $75-$100 per share.

With the closely watched XBI biotech index down 13% for the year, every M&A deal helps improve sentiment, but this one — maybe just a little. Bristol is paying $4.8 billion in cash to acquire Mirati, or $3.7 billion after accounting for Mirati’s cash. It’s a small bolt-on acquisition for Bristol, which isn’t overpaying.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Chemotherapy before breast cancer surgery might fuel metastasis

focus

WSS

Tuberculosis patients need more than just free medication

Sweden knocks USA out of World Cup in penalty kicks

Judge in Trump's classified documents case questions use of out

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

'Brian's Song' at 50 still offers lessons about cancer for today

Black vets could get higher VA benefits if race not used in lung test

hotspot

knowledge

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

Warren pushes Witty on UnitedHealth's control over physicians

DIEP, the 'gold standard' of breast reconstruction, is under threat

Google's generative AI to analyze medical images — and talk to docs

United colonoscopy coverage change 'may cost lives,' doctors say

As billionaires fund anti

Moonlake's readout produced a cash windfall. Risks remain

As health system earnings go up, health insurance stocks go down

Virginia high school admissions case could be legal follow

'Brian's Song' at 50 still offers lessons about cancer for today

leisure time

Most antidepressants don't work on kids, teens, study finds

Tuberculosis patients need more than just free medication

St. Louis police protesters begin picking up checks in $4.9 million settlement

The effects of a landmark ruling on DNA ownership are becoming clearer

Trump used to be more articulate. What could explain the change?

Flash flood warnings continue for parts of Missouri, Illinois

leisure time

focus

focus

entertainment